Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Comprehensive analysis of gut microbiota and fecal metabolites in patients with autism spectrum disorder

Open access
Zheng, Ruijuan, Huang, Silu, Feng, Pengya, Liu, Simeng, Jiang, Miaomiao, Li, Huijuan, Zheng, Pengyuan, Mi, Yang, Li, Enyao · 2025 · Frontiers in Microbiology

Abstract

Introduction: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and the presence of restricted, repetitive behaviors or interests. Studies have revealed that gut microbiota and their metabolism play important roles in ASD, and become the underlying mechanisms of ASD. Methods: In this study, we performed long-read 16S rRNA sequencing and untargeted metabolomics to comprehensively characterize the profiles of gut microbiota and fecal metabolites in 34 ASD patients and 18 healthy controls. The associations between gut microbiota, fecal metabolites and clinical symptoms were analyzed to screen related biomarkers for ASD. Results: The results showed the similarity of the overall microbial richness and diversity between ASD patients and controls, however, some specific bacterial taxa exhibited significant differences, including Klebsiella and Escherichia-Shigella at genera level, and Clostridium-sporogenes , Escherichia-coli-O157H7 and Bacteroides-ovatus at species level. The fecal metabolomics validated that a lot of metabolites had significantly differential levels, including a series of organic acids, amino acids and dopamine. Discussion: The associations of gut microbiota and fecal metabolites might shed new light on the pathogenesis of ASD and help us to understand the importance of gut microbiota as potential biomarkers and therapeutic targets in the development of ASD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2025.1557174

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Alpha diversity analysis. (A) Rarefaction curves; (B) rank-abundance distribution curve; (C) diversity and richness of gut microbiota in ASD and HC, including observed species, Chao1, ACE, Shannon, Simpson, and Coverage. There were no significant differences in the microbial richness and diversity between ASD and HC. ASD, autism spectrum disorder; HC, healthy control.
FIGURE 1 Alpha diversity analysis. (A) Rarefaction curves; (B) rank-abundance distribution curve; (C) diversity and richness of gut microbiota in ASD and HC, including observed species, Chao1, ACE, Shannon, Simpson, and Coverage. There were no significant differences in the microbial richness and diversity between ASD and HC. ASD, autism spectrum disorder; HC, healthy control.CC BY · PubMed Central
FIGURE 2 Beta diversity analysis. (A) PCA, (B) PCoA, (C) NMDS analysis results based on the OTU matrix of ASD patients and healthy controls. (D) The cladogram from LEfSe analysis revealed differential microbial taxonomy in ASD and HC group. (E) Histograms of LDA scores in ASD and HC, with a cutoff value of LDA score (log10) above 2.0.
FIGURE 2 Beta diversity analysis. (A) PCA, (B) PCoA, (C) NMDS analysis results based on the OTU matrix of ASD patients and healthy controls. (D) The cladogram from LEfSe analysis revealed differential microbial taxonomy in ASD and HC group. (E) Histograms of LDA scores in ASD and HC, with a cutoff value of LDA score (log10) above 2.0.CC BY · PubMed Central
FIGURE 3 Differences in the composition of gut microbiota between ASD and HC across various taxonomic levels. Bar plots showed the composition differences of gut microbiota at the phylum (A), genus (B) and species (C) levels in two groups. Boxplots revealed the relative abundance of several differential gut microbiota at the phylum (D), genus (E) and species (F) levels between ASD and HC. *p < 0.05, **p < 0.01; ***p < 0.001.
FIGURE 3 Differences in the composition of gut microbiota between ASD and HC across various taxonomic levels. Bar plots showed the composition differences of gut microbiota at the phylum (A), genus (B) and species (C) levels in two groups. Boxplots revealed the relative abundance of several differential gut microbiota at the phylum (D), genus (E) and species (F) levels between ASD and HC. *p < 0.05, **p < 0.01; ***p < 0.001.CC BY · PubMed Central
FIGURE 4 Fecal metabolomics profiles of ASD patients and HC by metabolomics analysis. (A) PCA plot of fecal metabolites in ASD and HC. (B) Score plot of OPLS-DA revealed that the composition of fecal metabolites were significantly different in ASD and HC. (C) Volcano plot showed the number of significantly differential fecal metabolites in ASD compared with HC. (D) Heatmap showed the top 10 up-regulated and 10 down-regulated metabolites in ASD compared to HC. (E) Pathway analysis showed that differential fecal metabolites were enriched in the related pathways.
FIGURE 4 Fecal metabolomics profiles of ASD patients and HC by metabolomics analysis. (A) PCA plot of fecal metabolites in ASD and HC. (B) Score plot of OPLS-DA revealed that the composition of fecal metabolites were significantly different in ASD and HC. (C) Volcano plot showed the number of significantly differential fecal metabolites in ASD compared with HC. (D) Heatmap showed the top 10 up-regulated and 10 down-regulated metabolites in ASD compared to HC. (E) Pathway analysis showed that differential fecal metabolites were enriched in the related pathways.CC BY · PubMed Central
FIGURE 5 Correlations between relative abundance of gut microbiota and differential fecal metabolites. The Spearman correlation coefficient was analyzed between the gut microbiota at the genus level and differential fecal metabolites in ASD compared to HC. The data was shown via heatmap, red and blue represented positive and negative correlations with different correlated degrees, respectively. *p < 0.05, **p < 0.01.
FIGURE 5 Correlations between relative abundance of gut microbiota and differential fecal metabolites. The Spearman correlation coefficient was analyzed between the gut microbiota at the genus level and differential fecal metabolites in ASD compared to HC. The data was shown via heatmap, red and blue represented positive and negative correlations with different correlated degrees, respectively. *p < 0.05, **p < 0.01.CC BY · PubMed Central
FIGURE 6 Correlations between clinical symptoms and gut microbiota composition or fecal metabolomics. The Spearman correlation coefficient was analyzed between clinical symptoms and gut microbiota composition (A) or fecal metabolomics (B) in ASD patients. The data was shown via heatmap, red and blue represented positive and negative correlations with different correlated degrees, respectively. *p < 0.05, **p < 0.01; ADOS_com, ADOS_communication; DQ, development quotient.
FIGURE 6 Correlations between clinical symptoms and gut microbiota composition or fecal metabolomics. The Spearman correlation coefficient was analyzed between clinical symptoms and gut microbiota composition (A) or fecal metabolomics (B) in ASD patients. The data was shown via heatmap, red and blue represented positive and negative correlations with different correlated degrees, respectively. *p < 0.05, **p < 0.01; ADOS_com, ADOS_communication; DQ, development quotient.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Cited by

See all 11

Metadata

Authors
Zheng, R., Huang, S., Feng, P., Liu, S., Jiang, M., Li, H., Zheng, P., Mi, Y., & Li, E.
Affiliations
  • Fifth Affiliated Hospital of Zhengzhou University (CN)
  • Department of Child Rehabilitation, The Fifth Affiliated Hospital of Zhengzhou University
  • Zhengzhou University (CN)
Corresponding author
  • Zheng, Pengyuan
  • Mi, Yang
Venue
Frontiers in Microbiology
Published
2025-04-25
Volume
16
Pages
1557174-1557174
ISSN
1664-302X (ISSN-L)
OpenAlex
W4409825182
Cited by
6
References
69
Citations by year
2026: 5 · 2025: 1
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
autism spectrum disorder, gut microbiota, fecal metabolites, biomarkers, Klebsiella, Escherichia-Shigella, Clostridium sporogenes, Bacteroides ovatus, organic acids, amino acids, dopamine, microbial diversity, ASD pathogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive analysis of gut microbiota and fecal metabolites in patients with autism spectrum disorder. https://app.cochat.ai/papers/10.3389/fmicb.2025.1557174
The paper
Zheng, R., Huang, S., Feng, P., Liu, S., Jiang, M., Li, H., Zheng, P., Mi, Y., & Li, E. (2025). Comprehensive analysis of gut microbiota and fecal metabolites in patients with autism spectrum disorder. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1557174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.